Can You Buy Retatrutide? What FDA Says About Unapproved GLP-1 Products
There is no approved retatrutide medicine to buy, so outside a registered clinical trial anything sold under the name is unapproved. FDA has been direct about what that means for products of this kind.
This page does not identify, rank or link to any seller, and it gives no advice on obtaining or using retatrutide. It summarizes what FDA has publicly said about unapproved GLP-1 drugs, which is not a statement about any one product.
There is no approved product
Retatrutide is investigational. It has no FDA-approved prescribing information, no approved dose and no authorized prescription product. Outside a registered clinical trial, where participants do not buy the study drug, anything sold as retatrutide is unapproved by definition.
What FDA has said about unapproved GLP-1 drugs
FDA’s statement on unapproved GLP-1 drugs used for weight loss says such products do not undergo FDA’s review for safety, effectiveness and quality before they are marketed. It adds that compounded drugs are not FDA approved, which means the agency does not review them for safety, effectiveness or quality.
The statement is about unapproved GLP-1 products in general. It does not single out retatrutide, and this page does not claim it does.
What a research-use label does and does not mean
FDA says it has warned companies that illegally sold unapproved drugs with false labeling, and notes that products labeled for research purposes have been sold directly to consumers for human use. It advises consumers to avoid products falsely labeled for research purposes or not for human consumption.
A research-use label is a statement made by a seller. It is not a test result and it is not a regulatory status. It does not establish identity, purity, sterility or potency.
Risks FDA names
FDA ties these to unapproved GLP-1 products generally. Retatrutide adds a further unknown, because published safety data does not extend beyond the length of the completed trials.
- False information on the product label, including pharmacies named on labels that do not exist
- Improper storage, with drugs arriving warm or with inadequate ice packs
- Dosing errors that led to adverse events, some requiring hospitalization
- Wrong ingredients, or too little, too much or no active ingredient
What to do instead
- Talk to a licensed clinician. Approved medicines in the same class exist, and a clinician can assess whether one suits you
- If you are interested in the research itself, read how trial enrolment works. A trial is supervised research, not a way to get the drug
- If you or someone you know has had a problem with an unapproved product, seek medical care and report it to FDA’s MedWatch program
Common Questions
Is there a legitimate way to buy retatrutide?
There is no approved retatrutide medicine. The supervised research route is a clinical trial, where participants do not buy the study drug.
Are research-use peptides the same as the drug in the trials?
No. Trial material is manufactured, labeled and supervised under the study protocol. A seller’s label does not establish the same identity, purity or potency.
Does FDA regulate research-use-only products?
FDA has warned companies that sold unapproved drugs with false research labeling, and says such products have been sold to consumers for human use. It advises avoiding products falsely labeled for research or not for human consumption.
What should I do if I feel unwell after using an unapproved product?
Contact a healthcare professional, or emergency services if it is urgent, and report the product to FDA’s MedWatch program.
References
- U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.
- ClinicalTrials.gov. TRIUMPH-1: A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight. NCT05929066. Record updated June 2026.
References were checked against the journal, PubMed or ClinicalTrials.gov record. Company-reported topline results are labeled as such.